RFP For GLP-1 Medication Access, Affordability & Management Solutions

The City of Cambridge, Massachusetts, is soliciting proposals under RFP COC-RFP-FY27-31207 for GLP-1 Medication Access, Affordability, and Management Solutions. The city seeks a direct-to-employer passthrough or subsidy model that allows approximately 800 eligible members to purchase GLP-1 medications through discounted cash-pay pharmacy channels or manufacturer direct-purchase programs, such as Eli Lilly's LillyDirect and Novo Nordisk's NovoCare Pharmacy. This solution must operate independently of the city's existing PBM formulary or medical benefits. Proposals must be submitted electronically via the procurement portal by 11:00 am on October 15, 2026. To be considered, proposers must be licensed pharmacies or pharmacy services organizations authorized to operate in Massachusetts and must maintain HIPAA-compliant data security practices. Key performance requirements include a commitment to a defined turnaround-time standard, with a median time of fewer than five business days from request to receipt being rated as highly advantageous. The implementation timeline requires member onboarding to begin by March 1, 2027, with prescription filling active by April 1, 2027. Awarding will be based on the most advantageous proposal, considering quality requirements and composite ratings. Contractors must adhere to various local and state regulations, including the Cambridge Living Wage Ordinance, the City of Cambridge CORI Policy, and the Truck Safety Ordinance for contracts exceeding 10,000 dollars annually. All deliveries must be made in original manufacturer packaging as inside deliveries to the city's destination. The contract will commence upon execution and may be extended at the city's discretion. Proposers are required to provide a total annual cost estimate for a three-year period based on an estimated 8,000 transactions per year, along with a Wage Theft Prevention Certification.